Results for tag: "Krystexxa"

Krystexxa is a brand of immune disorder drugs used to treat chronic gout. It is a pegloticase injection that works by breaking down uric acid in the body, which is the main cause of gout. Krystexxa is the only FDA-approved drug for the treatment of chronic gout in adult patients who have not responded to other therapies. It is administered as an intravenous infusion every two weeks. Krystexxa is a relatively new drug, having been approved by the FDA in 2010. It is used to treat a small subset of patients with chronic gout, and is not widely prescribed. However, it is an important treatment option for those who have not responded to other therapies. The Krystexxa market is made up of several companies, including Horizon Pharma, Savient Pharmaceuticals, and Horizon Therapeutics. These companies are involved in the research, development, and marketing of Krystexxa. They are also responsible for providing support and education to healthcare professionals and patients. Show Less Read more